K. Kuntz

发表

Modeling good research practices--overview: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--1.

Uwe Siebert, Andrew H Briggs, J Jaime Caro, 2012, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Development of an Empirically Calibrated Model of Gastric Cancer in Two High-Risk Countries

M. Ezzati, K. Kuntz, C. Kong, 2008, Cancer Epidemiology Biomarkers & Prevention.

Forecasting the Obesity Epidemic in the Aging U.S. Population

G. Colditz, K. Kuntz, Y. Wang, 2007, Obesity.

Economic Evaluation of Weight Loss Interventions in Overweight and Obese Women

K. Kuntz, C. Donaldson, S. Goldie, 2006, Obesity.

Meta-analysis: Diagnostic Accuracy of AntiCyclic Citrullinated Peptide Antibody and Rheumatoid Factor for Rheumatoid Arthritis

Kunihiro Nishimura, Isao Kamae, Seiji Kawano, 2007, Annals of Internal Medicine.

State-transition modeling: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--3.

D. Owens, U. Siebert, K. Kuntz, 2012, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Exercise echocardiography or exercise SPECT imaging? A meta-analysis of diagnostic test performance.

K. Kuntz, P. Douglas, K. Fleischmann, 1998, JAMA.

Cost effectiveness of mammography screening for Chinese women

B. Cowling, K. Kuntz, G. Leung, 2007, Cancer.

Pretreatment imaging workup for patients with intermittent claudication: a cost-effectiveness analysis.

G. Gazelle, K. Kuntz, M. Donaldson, 2003, Journal of vascular and interventional radiology : JVIR.

Cost-effectiveness of routine coronary angiography after acute myocardial infarction.

L. Goldman, M. Weinstein, K. Kuntz, 1996, Circulation.

HER-2 testing and trastuzumab therapy for metastatic breast cancer: a cost-effectiveness analysis.

M. Weinstein, E. Winer, E. Elkin, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Evaluating Test Strategies for Colorectal Cancer Screening: A Decision Analysis for the U.S. Preventive Services Task Force

Amy B. Knudsen, A. Zauber, K. Kuntz, 2008, Annals of Internal Medicine.

Rescreening of Persons With a Negative Colonoscopy Result: Results From a Microsimulation Model

G. Gazelle, K. Kuntz, D. Schrag, 2012, Annals of Internal Medicine.

Decision and Simulation Modeling in Systematic Reviews

R. Kane, K. Kuntz, S. Kulasingam, 2013 .

Exercise echocardiography or exercise SPECT imaging? A meta-analysis of diagnostic test performance.

K. Kuntz, P. Douglas, K. Fleischmann, 1998, JAMA.

Mutations in progranulin are a major cause of ubiquitin-positive frontotemporal lobar degeneration.

S. Melquist, M. Mesulam, B. Boeve, 2006, Human molecular genetics.

Plasma progranulin levels predict progranulin mutation status in frontotemporal dementia patients and asymptomatic family members

R. Petersen, B. Boeve, D. Dickson, 2009, Brain : a journal of neurology.

Expert panel vs decision-analysis recommendations for postdischarge coronary angiography after myocardial infarction.

L Goldman, M C Weinstein, J Tsevat, 1999, JAMA.

Perioperative imaging strategies for carotid endarterectomy. An analysis of morbidity and cost-effectiveness in symptomatic patients.

R. Edelman, J. Polak, K. Kuntz, 1995, JAMA.

Optimizing adjuvant endocrine therapy in postmenopausal women with early-stage breast cancer: a decision analysis.

E. Winer, K. Kuntz, H. Burstein, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Effect of verification bias on screening for prostate cancer by measurement of prostate-specific antigen.

William J Catalona, Anthony V D'Amico, Karen M Kuntz, 2003, The New England journal of medicine.

The impact of tumor progesterone receptor status on optimal adjuvant endocrine therapy for postmenopausal patients with early‐stage breast cancer

E. Winer, K. Kuntz, H. Burstein, 2006, Cancer.

Radiation T herapy P lus T amoxifen V ersus T amoxifen A lone After B reast-Conservin g S urgery i n P ostmenopausal W omen With S tage I B reast C ancer: A D ecision A nalysis

A. Recht, K. Kuntz, R. Punglia, 2003 .

Radiation therapy plus tamoxifen versus tamoxifen alone after breast-conserving surgery in postmenopausal women with stage I breast cancer: a decision analysis.

A. Recht, K. Kuntz, R. Punglia, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Cost-effectiveness of antibiotic prophylaxis for dental patients with prosthetic joints: Comparisons of antibiotic regimens for patients with total hip arthroplasty.

M. Swiontkowski, K. Kuntz, D. Skaar, 2015, Journal of the American Dental Association.

Potential Bias Associated with Modeling the Effectiveness of Healthcare Interventions in Reducing Mortality Using an Overall Hazard Ratio

K. Kuntz, F. Alarid-Escudero, 2019, PharmacoEconomics.

Contribution of H. pylori and Smoking Trends to US Incidence of Intestinal-Type Noncardia Gastric Adenocarcinoma: A Microsimulation Model

M. Ezzati, K. Kuntz, D. Schrag, 2013, PLoS medicine.

Characterization and Valuation of the Uncertainty of Calibrated Parameters in Microsimulation Decision Models

Nicholson T. Collier, Amy B. Knudsen, K. Kuntz, 2019, Frontiers in Physiology.

Prioritizing Future Research on Allopurinol and Febuxostat for the Management of Gout: Value of Information Analysis

Hyon K. Choi, K. Kuntz, E. Jutkowitz, 2017, PharmacoEconomics.

Cost-effectiveness of surveillance with CT colonography after resection of colorectal cancer

A. Zauber, J. Beck, K. Kuntz, 2020, BMJ open gastroenterology.

Stool DNA Testing to Screen for Colorectal Cancer in the Medicare Population

Amy B. Knudsen, A. Zauber, K. Kuntz, 2010, Annals of Internal Medicine.

Comorbidity as a correlate of length of stay for hospitalized patients with acute chest pain

E. Cook, L. Goldman, K. Kuntz, 1996, Journal of General Internal Medicine.

Should endomyocardial biopsy be performed for detection of myocarditis? A decision analytic approach.

K. Kuntz, J. Hare, P. Hroboň, 1998, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Impact of preoperative staging and chemoradiation versus postoperative chemoradiation on outcome in patients with rectal cancer: a decision analysis.

K. Kuntz, S. Syngal, J. Saltzman, 2004, Journal of the National Cancer Institute.

Completion Lymph Node Dissection or Observation for Melanoma Sentinel Lymph Node Metastases: A Decision Analysis

K. Kuntz, Pamela R. Portschy, T. Tuttle, 2016, Annals of Surgical Oncology.

Estimating Population-Based Recurrence Rates of Colorectal Cancer over Time in the United States

K. Kuntz, D. Schrag, E. Aas, 2020, Cancer Epidemiology, Biomarkers & Prevention.

M. Weinstein, K. Kuntz, Shaun Parsons, 1997, Annals of Internal Medicine.

Characterization and Valuation of the Uncertainty of Calibrated Parameters in Microsimulation Decision Models

K. Kuntz, A. Knudsen, N. Collier, 2022, Frontiers in Physiology.

Life Expectancy Biases in Clinical Decision Modeling

M. Weinstein, K. Kuntz, 1995, Medical decision making : an international journal of the Society for Medical Decision Making.

Prevalence of hematopoietic cell transplant survivors in the United States.

K. Kuntz, K. Robien, Stephanie J. Lee, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Hospital Characteristics Associated With Maintenance or Improvement of Guideline-recommended Lymph Node Evaluation for Colon Cancer

J. Begun, K. Kuntz, T. Tuttle, 2013, Medical care.

Cost-effectiveness of spinal manipulation, exercise, and self-management for spinal pain using an individual participant data meta-analysis approach: a study protocol

K. Kuntz, G. Bronfort, J. Nyman, 2018, Chiropractic & Manual Therapies.

Cost-effectiveness Analysis of Active Surveillance Strategies for Men with Low-risk Prostate Cancer.

K. Kuntz, N. Lawrentschuk, N. Sathianathen, 2019, European urology.

A Cost-effectiveness Analysis of Systemic Therapy for Metastatic Hormone-sensitive Prostate Cancer.

K. Kuntz, N. Lawrentschuk, D. Murphy, 2019, European urology oncology.

Troponin T as a marker for myocardial ischemia in patients undergoing major noncardiac surgery.

E. Cook, L. Goldman, K. Kuntz, 1996, The American journal of cardiology.

Cost-Effectiveness Analysis of Computerized Tomography in the Routine Follow-Up of Patients After Primary Treatment for Hodgkin's Disease

A. Ng, K. Kuntz, B. Guadagnolo, 2007 .

Costs and effectiveness of staging and treatment options in early-stage Hodgkin's disease.

A. Ng, K. Kuntz, J. Weeks, 2001, International journal of radiation oncology, biology, physics.

Open versus endoscopic carpal tunnel release: a decision analysis.

J. Katz, K. Kuntz, B. Simmons, 1999, The Journal of hand surgery.

A Comparison of HU12 and HU13 Utility Scores in Alzheimer's Disease

M. Weinstein, D. Feeny, K. Kuntz, 2000, Medical decision making : an international journal of the Society for Medical Decision Making.

178 Evaluating the Benefits and Harms of Colorectal Cancer Screening Strategies: A Collaborative Modeling Approach to Inform the US Preventive Services Task Force

A. Zauber, K. Kuntz, I. Lansdorp-Vogelaar, 2016 .

Estimation of Mortality Rates for Disease Simulation Models Using Bayesian Evidence Synthesis

G Scott Gazelle, Milton C Weinstein, Alan M Zaslavsky, 2006, Medical decision making : an international journal of the Society for Medical Decision Making.

Cost-effectiveness of interferon beta-1a, interferon beta-1b, and glatiramer acetate in newly diagnosed non-primary progressive multiple sclerosis.

Amit Bar-Or, Milton C Weinstein, Karen M Kuntz, 2004, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Patient and community preferences for treatments and health states in multiple sclerosis

Amit Bar-Or, Milton C Weinstein, Karen M Kuntz, 2003, Multiple sclerosis.

Cost-Effectiveness of Hepatic Metastasectomy in Patients With Metastatic Colorectal Carcinoma: A State-Transition Monte Carlo Decision Analysis

G Scott Gazelle, Milton C Weinstein, Karen M Kuntz, 2003, Annals of surgery.

Modeling for health care and other policy decisions: uses, roles, and validity.

J D Graham, M C Weinstein, P J Neumann, 2001, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Extracolonic findings from CTC: balancing risks and benefits.

A. Zauber, C. Rutter, K. Kuntz, 2009, AJR. American journal of roentgenology.

The cost-effectiveness of vaccination against Lyme disease.

M. Liang, C. Phillips, K. Kuntz, 2001, Archives of internal medicine.

Survival outcomes after contralateral prophylactic mastectomy: a decision analysis.

K. Kuntz, Pamela R. Portschy, T. Tuttle, 2014, Journal of the National Cancer Institute.

Supplementary appendix to: Non-identiﬁability in model calibration and implications for medical decision making

K. Kuntz, E. Enns, R. MacLehose, 2018 .

Will Test-Specific Adherence Predict the Best Colorectal Cancer Screening Strategy?

A. Zauber, K. Kuntz, M. Ballegooijen, 2009 .

Concordance of preoperative clinical risk with angiographic severity of coronary artery disease in patients undergoing vascular surgery.

S. Paul, K. Eagle, K. Kuntz, 1996, Circulation.

Estimating long-term effectiveness of lung cancer screening in the Mayo CT screening study.

Stephen J. Swensen, Milton C. Weinstein, Chung Yin Kong, 2008, Radiology.

Laparotomy V ersus N o L aparotomy i n t he M anagement of E arly-Stage, F avorable-Progno sis H odgkin's D isease: A D ecision A nalysis

A. Ng, K. Kuntz, J. Weeks, 1999 .

Validation of Colorectal Cancer Models on Long-term Outcomes from a Randomized Controlled Trial

Amy B. Knudsen, A. Zauber, C. Rutter, 2020, Medical decision making : an international journal of the Society for Medical Decision Making.

Perceptions of Contralateral Breast Cancer: An Overestimation of Risk

K. Kuntz, T. Tuttle, A. Abbott, 2011, Annals of Surgical Oncology.

Using economic analysis to evaluate the potential of multimodality therapy for elderly patients with locally advanced pancreatic cancer.

C. Earle, K. Kuntz, J. Weeks, 2007, International journal of radiation oncology, biology, physics.

Contribution of Screening and Survival Differences to Racial Disparities in Colorectal Cancer Rates

Amy B. Knudsen, A. Jemal, A. Zauber, 2012, Cancer Epidemiology, Biomarkers & Prevention.

Impact of age, benign prostatic hyperplasia, and cancer on prostate‐specific antigen level

A. D'Amico, W. Catalona, K. Kuntz, 2006, Cancer.

Incorporating Biomarkers into the Primary Prostate Biopsy Setting: A Cost‐Effectiveness Analysis

K. Kuntz, N. Lawrentschuk, D. Murphy, 2018, The Journal of urology.

Future Directions for Cost-effectiveness Analyses in Health and Medicine

Douglas K Owens, David Feeny, Thomas A Trikalinos, 2018, Medical decision making : an international journal of the Society for Medical Decision Making.

Recommendations on Perspectives for the Reference Case

T. Trikalinos, M. Sculpher, D. Feeny, 2016 .

The cost-effectiveness of HLA-B*5801 screening to guide initial urate-lowering therapy for gout in the United States.

Hyon K. Choi, K. Kuntz, N. Lu, 2017, Seminars in arthritis and rheumatism.

Exercise Echocardiography vs Exercise SPECT Testing—Reply

K. Kuntz, P. Douglas, K. Fleischmann, 1999 .

Cost-effectiveness of captopril therapy after myocardial infarction.

L. Goldman, G. Lamas, K. Kuntz, 1995, Journal of the American College of Cardiology.

Post‐lumbar puncture headaches

J. Stevens, E. Kokmen, K. Kuntz, 1992, Neurology.

Health values of patients infected with human immunodeficiency virus. Relationship to mental health and physical functioning.

M C Weinstein, J Tsevat, K M Kuntz, 1996, Medical care.

Bias Associated with Failing to Incorporate Dependence on Event History in Markov Models

K. Kuntz, J. Ringel, T. Bentley, 2010, Medical decision making : an international journal of the Society for Medical Decision Making.

272 Cost-Effectiveness of CT Colonography to Screen for Colorectal Cancer: Report to Center for Medicare and Medicaid Services from Cancer Intervention and Surveillance Modeling Network (CISNET)

A. Zauber, J. Savarino, C. Rutter, 2009 .

Costs and effectiveness of angiotensin converting enzyme inhibition in patients with congestive heart failure.

M. Weinstein, S. Paul, K. Eagle, 1994, Archives of internal medicine.

An Asthma Policy Model

Scott T. Weiss, Anne L. Fuhlbrigge, Karen M. Kuntz, 2005 .

A cost effectiveness analysis of treatment options for methotrexate-naive rheumatoid arthritis.

Hyon K. Choi, K. Kuntz, J. Seeger, 2002, The Journal of rheumatology.

Cost-effectiveness of accepted measures for intervention in coronary heart disease.

K. Kuntz, T. Lee, 1995, Coronary artery disease.

Forced Expiratory Volume in 1 Second Percentage Improves the Classification of Severity Among Children With Asthma

K. Kuntz, A. Fuhlbrigge, A. Paltiel, 2006, Pediatrics.

Is carotid endarterectomy cost-effective? An analysis of symptomatic and asymptomatic patients.

K. Kuntz, K. Kent, Kent Kc, 1996, Circulation.

A cost-effectiveness analysis of pretreatment DPYD and UGT1A1 screening in patients with metastatic colorectal cancer (mCRC) treated with FOLFIRI+bevacizumab (FOLFIRI+Bev).

K. Kuntz, E. Lou, D. Stenehjem, 2020 .

Preoperative assessment of the carotid bifurcation. Can magnetic resonance angiography and duplex ultrasonography replace contrast arteriography?

R. Edelman, J. Polak, K. Kuntz, 1995, Stroke.

FEV(1) is associated with risk of asthma attacks in a pediatric population.

Barrett T. Kitch, D. Dockery, K. Kuntz, 2001, The Journal of allergy and clinical immunology.

Cost-effectiveness analysis of mammography screening in Hong Kong Chinese using state-transition Markov modelling.

B. Cowling, K. Kuntz, I. Wong, 2010, Hong Kong medical journal = Xianggang yi xue za zhi.

Cost Effectiveness of Mammography Screening for Chinese Women. Cancer. 2007;110:885-895

B. Cowling, K. Kuntz, G. Leung, 2010 .

Characterization of frontotemporal dementia and/or amyotrophic lateral sclerosis associated with the GGGGCC repeat expansion in C9ORF72

David T. Jones, C. Jack, R. Petersen, 2012, Brain : a journal of neurology.

The Relationship between Risk Attitude and Treatment Choice in Patients with Relapsing-Remitting Multiple Sclerosis

M. Weinstein, A. Bar-Or, L. Prosser, 2002, Medical decision making : an international journal of the Society for Medical Decision Making.

Computing Expected Value of Partial Sample Information from Probabilistic Sensitivity Analysis Using Linear Regression Metamodeling

Hawre Jalal, Jeremy D Goldhaber-Fiebert, Karen M Kuntz, 2015, Medical decision making : an international journal of the Society for Medical Decision Making.

Limitations of Acceptability Curves for Presenting Uncertainty in Cost-Effectiveness Analysis

Bas Groot Koerkamp, Theo Stijnen, Milton C Weinstein, 2007, Medical decision making : an international journal of the Society for Medical Decision Making.

"Time Traveling Is Just Too Dangerous" but Some Methods Are Worth Revisiting: The Advantages of Expected Loss Curves Over Cost-Effectiveness Acceptability Curves and Frontier.

Fernando Alarid-Escudero, Hawre Jalal, Eva A Enns, 2019, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Modeling Good Research Practices—Overview

Uwe Siebert, Andrew H Briggs, J Jaime Caro, 2012, Medical decision making : an international journal of the Society for Medical Decision Making.

Cost-effectiveness of diagnostic strategies for patients with chest pain.

K. Kuntz, P. Douglas, K. Fleischmann, 1999, Annals of internal medicine.

State-Transition Modeling

Douglas K Owens, Oguzhan Alagoz, Uwe Siebert, 2012, Medical decision making : an international journal of the Society for Medical Decision Making.

Cost-Effective Diagnostic Checklists for Meningitis in Resource-Limited Settings

K. Kuntz, D. Boulware, B. Virnig, 2013, Journal of acquired immune deficiency syndromes.

Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses: Second Panel on Cost-Effectiveness in Health and Medicine.

T. Trikalinos, M. Sculpher, D. Feeny, 2016, JAMA.

The comparative safety of tumor necrosis factor inhibitors in rheumatoid arthritis: a meta-analysis update of 44 trials.

Hyon K. Choi, K. Kuntz, T. Shamliyan, 2014, The American journal of medicine.

The clinical effectiveness and cost-effectiveness of screening for anal squamous intraepithelial lesions in homosexual and bisexual HIV-positive men.

M. Weinstein, K. Freedberg, J. Palefsky, 1999, JAMA.

Project PREVENT: A Randomized Trial to Reduce Multiple Behavioral Risk Factors for Colon Cancer

E. Clipp, E. Puleo, C. McBride, 2005, Cancer Epidemiology Biomarkers & Prevention.

Cost-Effectiveness of DNA Stool Testing to Screen for Colorectal Cancer

Amy B. Knudsen, A. Zauber, K. Kuntz, 2007 .

Benefits of Colonoscopic Surveillance and Prophylactic Colectomy in Patients with Hereditary Nonpolyposis Colorectal Cancer Mutations

Deborah Schrag, J. Garber, K. Kuntz, 1998, Annals of Internal Medicine.

Novel Mutations in TARDBP (TDP-43) in Patients with Familial Amyotrophic Lateral Sclerosis

D. Geschwind, L. Petrucelli, R. Petersen, 2008, PLoS genetics.

Decision analysis on alternative treatment strategies for favorable-prognosis, early-stage Hodgkin's disease.

K M Kuntz, A. Ng, K. Kuntz, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Laparotomy versus no laparotomy in the management of early-stage, favorable-prognosis Hodgkin's disease: a decision analysis.

A. Ng, K. Kuntz, J. Weeks, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

CDX2 Biomarker Testing and Adjuvant Therapy for Stage II Colon Cancer: An Exploratory Cost-Effectiveness Analysis.

K. Kuntz, D. Schrag, F. Alarid-Escudero, 2021, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Lymph node evaluation for colon cancer in an era of quality guidelines: who improves?

J. Begun, K. Kuntz, T. Tuttle, 2013, Journal of oncology practice.

Association between lymph node evaluation for colon cancer and node positivity over the past 20 years.

J. Begun, K. Kuntz, T. Tuttle, 2011, JAMA.

Cost-Effectiveness of Integrating a Clinical Decision Rule and Staged Imaging Protocol for Diagnosis of Appendicitis.

K. Kuntz, F. Sainfort, S. Gregory, 2016, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Cost-effectiveness of cervical cancer screening with human papillomavirus DNA testing and HPV-16,18 vaccination.

J. Salomon, K. Kuntz, N. Stout, 2008, Journal of the National Cancer Institute.

Secular trends in colon and rectal cancer relative survival.

Eric J Feuer, Deborah Schrag, Karen M Kuntz, 2013, Journal of the National Cancer Institute.

Cost effectiveness of aspirin, clopidogrel, or both for secondary prevention of coronary heart disease.

Karen M Kuntz, L. Goldman, K. Kuntz, 2002, The New England journal of medicine.

Cost effectiveness of human papillomavirus testing to augment cervical cancer screening in women infected with the human immunodeficiency virus.

M. Weinstein, K. Freedberg, T. Wright, 2001, The American journal of medicine.

The Costs, Clinical Benefits, and Cost-Effectiveness of Screening for Cervical Cancer in HIV-Infected Women

M. Weinstein, K. Freedberg, K. Kuntz, 1999, Annals of Internal Medicine.

Evaluation of hormonal testing in the screening forin vitro fertilization (IVF) of women with tubal factor infertility

R. Barbieri, K. Kuntz, M. Laufer, 1995, Journal of Assisted Reproduction and Genetics.

Colorectal Cancer Screening: An Updated Modeling Study for the US Preventive Services Task Force.

Amy B. Knudsen, Jennifer S. Lin, E. Feuer, 2021, JAMA.

Prospective study of wound complications in continuous infrainguinal incisions after lower limb arterial reconstruction: incidence, risk factors, and cost.

K. Kuntz, K. Kent, J. Skillman, 1996, Surgery.

Life expectancy gains from cancer prevention strategies for women with breast cancer and BRCA1 or BRCA2 mutations.

J. Garber, K. Kuntz, D. Schrag, 2000, JAMA.

Decision analysis--effects of prophylactic mastectomy and oophorectomy on life expectancy among women with BRCA1 or BRCA2 mutations.

K M Kuntz, J. Garber, K. Kuntz, 1997, The New England journal of medicine.

Cost-effectiveness of screening for anal squamous intraepithelial lesions and anal cancer in human immunodeficiency virus-negative homosexual and bisexual men.

M. Weinstein, K. Freedberg, J. Palefsky, 2000, The American journal of medicine.

Models in the Development of Clinical Practice Guidelines

Douglas K Owens, Timothy J Wilt, Heidi D Nelson, 2014, Annals of Internal Medicine.

Population-level changes in folate intake by age, gender, and race/ethnicity after folic acid fortification.

W. Willett, M. Weinstein, K. Kuntz, 2006, American journal of public health.

Cost-effectiveness of pravastatin therapy for survivors of myocardial infarction with average cholesterol levels.

M C Weinstein, J Tsevat, K M Kuntz, 2001, American heart journal.

Effects of Helicobacter pylori infection and smoking on gastric cancer incidence in China: a population-level analysis of trends and projections

M. Ezzati, K. Kuntz, S. Goldie, 2009, Cancer Causes & Control.

The costs and cost-effectiveness of unrelated donor bone marrow transplantation for chronic phase chronic myelogenous leukemia.

K. Kuntz, J. Weeks, C. Anasetti, 1998, Blood.

Trade‐offs Between Efficacy and Cardiac Toxicity of Adjuvant Chemotherapy in Early‐Stage Breast Cancer Patients: Do Competing Risks Matter?

K. Kuntz, A. Blaes, F. Alarid-Escudero, 2017, The breast journal.

Cost-effectiveness of a multitarget stool DNA test for colorectal cancer screening of Medicare beneficiaries

Amy B. Knudsen, A. Zauber, C. Rutter, 2019, PloS one.

Perceptions of Contralateral Breast Cancer Risk: A Prospective, Longitudinal Study

K. Kuntz, Pamela R. Portschy, S. Marmor, 2015, Annals of Surgical Oncology.

Optimal colorectal cancer screening in states' low-income, uninsured populations—the case of South Carolina.

Amy B. Knudsen, A. Zauber, K. Kuntz, 2015, Health services research.

Cost-effectiveness of fusion with and without instrumentation for patients with degenerative spondylolisthesis and spinal stenosis.

R. K. Snider, J. Weinstein, K. Kuntz, 2000, Spine.

Model for incorporating social context in health behavior interventions: applications for cancer prevention for working-class, multiethnic populations.

K. Emmons, L. Berkman, K. Kuntz, 2003, Preventive medicine.

Reevaluating the Evidence for Intensive Postoperative Extracolonic Surveillance for Nonmetastatic Colorectal Cancer.

J. Beck, K. Kuntz, J. Nyman, 2021, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Clinical characterization of a kindred with a novel 12-octapeptide repeat insertion in the prion protein gene.

C. Jack, J. Ellison, B. Boeve, 2011, Archives of neurology.

Karen M Kuntz, Ann G Zauber, Iris Lansdorp-Vogelaar, 2011, AJR. American journal of roentgenology.

Children with headache suspected of having a brain tumor: a cost-effectiveness analysis of diagnostic strategies.

S. Pomeroy, K. Kuntz, L. S. Medina, 2001, Pediatrics.

Methodological design for economic evaluation in Public Access Defibrillation (PAD) trial.

K. Kuntz, G. Nichol, W. Longstreth, 2005, American heart journal.

A cost-effectiveness analysis of treatment options for patients with methotrexate-resistant rheumatoid arthritis.

K. Kuntz, J. Seeger, H. Choi, 2000, Arthritis and rheumatism.

Return to work after deceased donor kidney transplant under the kidney allocation system

Bjorn P. Berg, K. Kuntz, B. Dowd, 2021, Clinical transplantation.

Cost-effectiveness of inhaled corticosteroids in adults with mild-to-moderate asthma: results from the asthma policy model.

Barrett T. Kitch, K. Kuntz, A. Fuhlbrigge, 2001, The Journal of allergy and clinical immunology.

A novel approach to defining the relationship between lung function and symptom status in asthma.

Barrett T. Kitch, K. Kuntz, A. Fuhlbrigge, 2002, Journal of clinical epidemiology.

Cost-effectiveness of inhaled steroids in asthma: impact of effect on bone mineral density.

K. Kuntz, A. Fuhlbrigge, A. Paltiel, 2006, The Journal of allergy and clinical immunology.

Cost-effectiveness of computed tomographic colonography screening for colorectal cancer in the medicare population.

Amy B. Knudsen, A. Zauber, J. Savarino, 2010, Journal of the National Cancer Institute.

Exploring the cost‐effectiveness of Helicobacter pylori screening to prevent gastric cancer in China in anticipation of clinical trial results

M. Ezzati, K. Kuntz, S. Goldie, 2009, International journal of cancer.

Newborns with suspected occult spinal dysraphism: a cost-effectiveness analysis of diagnostic strategies.

K. Kuntz, L. S. Medina, K. Crone, 2001, Pediatrics.

Annals of Internal Medicine Cost-Effectiveness of Diagnostic Strategies for Patients with Chest Pain

K. Kuntz, P. Douglas, K. Fleischmann, 1999 .

Emergency Department Triage Strategies for Acute Chest Pain Using Creatine KinaseMB and Troponin I Assays: A Cost-Effectiveness Analysis

K. Kuntz, Thomas Lee, P. Johnson, 1999, Annals of Internal Medicine.

Cost-Effectiveness of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitor Therapy in Older Patients with Myocardial Infarction

J. Avorn, K. Kuntz, D. Ganz, 2000, Annals of Internal Medicine.

Cost effectiveness and screening interval of lipid screening in Hodgkin's lymphoma survivors.

A. Ng, K. Kuntz, Aileen B Chen, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Computed tomography screening for lung cancer in Hodgkin's lymphoma survivors: decision analysis and cost-effectiveness analysis.

C. Earle, A. Ng, K. Kuntz, 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

Outcomes and cost-effectiveness of alternative staging strategies for non-small-cell lung cancer.

K. Kuntz, S. Mentzer, N. Esnaola, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Physicians' attitudes toward misdiagnosis of pulmonary embolism: a utility analysis.

D. Z. Sands, K. Kuntz, M. Rosen, 2000, Academic radiology.

Health utilities in Alzheimer's disease: a cross-sectional study of patients and caregivers.

M. Weinstein, K. Kuntz, P. Neumann, 1999, Medical care.

Nonidentifiability in Model Calibration and Implications for Medical Decision Making

Fernando Alarid-Escudero, Eva A. Enns, Richard F. MacLehose, 2018, Medical decision making : an international journal of the Society for Medical Decision Making.

Modeling the potential impact of a prescription drug copayment increase on the adult asthmatic medicaid population.

K. Kuntz, A. Fuhlbrigge, A. Paltiel, 2008, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Prominent phenotypic variability associated with mutations in Progranulin

C. Jack, R. Petersen, R. Ivnik, 2009, Neurobiology of Aging.

Estimating the Natural History of Cervical Carcinogenesis Using Simulation Models: A CISNET Comparative Analysis.

K. Kuntz, M. van Ballegooijen, S. Kulasingam, 2019, Journal of the National Cancer Institute.

Using Cerebrospinal Fluid Biomarker Testing to Target Treatment to Patients with Mild Cognitive Impairment: A Cost-Effectiveness Analysis

J. McCarten, R. Kane, K. Kuntz, 2017, PharmacoEconomics - Open.

Projected life-expectancy gains with statin therapy for individuals with elevated C-reactive protein levels.

P. Ridker, K. Kuntz, G. Blake, 2002, Journal of the American College of Cardiology.

Potential cost-effectiveness of C-reactive protein screening followed by targeted statin therapy for the primary prevention of cardiovascular disease among patients without overt hyperlipidemia.

P. Ridker, K. Kuntz, G. Blake, 2003, The American journal of medicine.

Alzheimer disease-like phenotype associated with the c.154delA mutation in progranulin.

R. Petersen, B. Boeve, Glenn E. Smith, 2010, Archives of neurology.

Measuring Alzheimer’s disease progression with transition probabilities

K S Kosik, P J Neumann, K M Kuntz, 2001, Neurology.

Risk Stratification Using Cerebrospinal Fluid Biomarkers in Patients with Mild Cognitive Impairment: An Exploratory Analysis.

J. McCarten, R. Kane, K. Kuntz, 2015, Journal of Alzheimer's disease : JAD.

Societal and Family Lifetime Cost of Dementia: Implications for Policy

R. Kane, K. Kuntz, B. Dowd, 2017, Journal of the American Geriatrics Society.

Cost‐effectiveness of treatment and endoscopic surveillance of precancerous lesions to prevent gastric cancer

M. Ezzati, K. Kuntz, C. Hur, 2010, Cancer.

Cost-effectiveness of lay responder defibrillation for out-of-hospital cardiac arrest.

M. Weisfeldt, K. Kuntz, G. Nichol, 2009, Annals of emergency medicine.

Estimating the Energy Gap Among US Children: A Counterfactual Approach

Karen M. Kuntz, Steven L. Gortmaker, S. Gortmaker, 2006, Pediatrics.

Cost-effectiveness Evaluation of Laparoscopic Versus Robotic Minimally Invasive Colectomy.

Mary R. Kwaan, Vlad V. Simianu, K. Kuntz, 2020, Annals of surgery.

A Cost-Effectiveness Evaluation of Surgical Approaches to Proctectomy

Mary R. Kwaan, Vlad V. Simianu, K. Kuntz, 2020, Journal of Gastrointestinal Surgery.

Cost-effectiveness of low dose corticosteroids versus non-steroidal anti-inflammatory drugs and COX-2 specific inhibitors in the long-term treatment of rheumatoid arthritis.

M. Liang, K. Kuntz, S. Bae, 2003, Rheumatology.

Cost-Effectiveness of Risk-Stratified Colorectal Cancer Screening Based on Polygenic Risk: Current Status and Future Potential

Elizabeth M. Webber, Marc S. Williams, K. Goddard, 2019, JNCI cancer spectrum.

Estimation of Benefits, Burden, and Harms of Colorectal Cancer Screening Strategies: Modeling Study for the US Preventive Services Task Force.

Karen M Kuntz, Ann G Zauber, Iris Lansdorp-Vogelaar, 2016, JAMA.

Clinical and echocardiographic correlates of health status in patients with acute chest pain

L. Goldman, K. Kuntz, P. Come, 1997, Journal of General Internal Medicine.

Is fecal occult blood testing more sensitive for left- versus right-sided colorectal neoplasia? A systematic literature review

Amy B. Knudsen, H. Brenner, K. Kuntz, 2011, Expert review of molecular diagnostics.

Duplex ultrasound criteria for the identification of carotid stenosis should be laboratory specific.

J. Polak, K. Kuntz, K. Kent, 1997, Stroke.

How should individuals with a false‐positive fecal occult blood test for colorectal cancer be managed? A decision analysis

K. Kuntz, A. Knudsen, U. Haug, 2012, International journal of cancer.

Evaluating Test Strategies for Colorectal Cancer Screening—Age to Begin, Age to Stop, and Timing of Screening Intervals

A. Zauber, K. Kuntz, I. Lansdorp-Vogelaar, 2009 .

Effects of rofecoxib and naproxen on life expectancy among patients with rheumatoid arthritis: a decision analysis.

Hyon K. Choi, K. Kuntz, J. Seeger, 2004, The American journal of medicine.

Noninvasive Imaging for the Diagnosis of Coronary Artery Disease: Focusing the Development of New Diagnostic Technology

M G Hunink, K M Kuntz, T J Brady, 1999, Annals of Internal Medicine.

The Curve of Optimal Sample Size (COSS): A Graphical Representation of the Optimal Sample Size from a Value of Information Analysis

Fernando Alarid-Escudero, Hawre Jalal, Karen M Kuntz, 2019, PharmacoEconomics.

A single measure of FEV1 is associated with risk of asthma attacks in long-term follow-up.

A David Paltiel, Karen M Kuntz, Scott T Weiss, 2004, Chest.

Multiparameter calibration of a natural history model of cervical cancer.

Karen M Kuntz, Natasha K Stout, Sue J Goldie, 2007, American journal of epidemiology.

A Meta-analysis of Diagnostic Test Performance

K. Kuntz, P. Douglas, K. Fleischmann, 2000 .

Adjuvant Ovarian Suppression Versus Chemotherapy for Premenopausal, Hormone-responsive Breast Cancer: Quality of Life and Efficacy Tradeoffs

Elena B. Elkin, Milton C. Weinstein, Karen M. Kuntz, 2005, Breast Cancer Research and Treatment.

Network meta-analysis of margin threshold for women with ductal carcinoma in situ.

H. Chu, R. Kane, K. Kuntz, 2012, Journal of the National Cancer Institute.

A cost-effectiveness analysis of axillary node dissection in postmenopausal women with estrogen receptor-positive breast cancer and clinically negative axillary nodes.

K. Kuntz, N. Col, R. Orr, 1999, Surgery.

Incorporating margin status information in treatment decisions for women with ductal carcinoma in situ: a decision analysis

R. Kane, K. Kuntz, T. Tuttle, 2010, Breast Cancer Research and Treatment.

Assessing the Sensitivity of Decision-Analytic Results to Unobserved Markers of Risk: Defining the Effects of Heterogeneity Bias

K. Kuntz, S. Goldie, 2002, Medical decision making : an international journal of the Society for Medical Decision Making.

Is routine duplex ultrasound surveillance after carotid endarterectomy cost-effective?

K. Kuntz, K. Kent, S. Patel, 1998, Surgery.

Derivation of Background Mortality by Smoking and Obesity in Cancer Simulation Models

E. Feuer, A. Zauber, B. Graubard, 2013, Medical decision making : an international journal of the Society for Medical Decision Making.

Comparative economic evaluation of data from the ACRIN National CT Colonography Trial with three cancer intervention and surveillance modeling network microsimulations.

Amy B. Knudsen, E. Feuer, A. Zauber, 2011, Radiology.

A cost-effectiveness analysis of folic acid fortification policy in the United States

W. Willett, M. Weinstein, K. Kuntz, 2009, Public Health Nutrition.

Quality of care along the cancer continuum: does receiving adequate lymph node evaluation for colon cancer lead to comprehensive postsurgical care?

J. Begun, K. Kuntz, T. Tuttle, 2012, Journal of the American College of Surgeons.

A Critical Pathway for Management of Patients with Acute Chest Pain Who Are at Low Risk for Myocardial Ischemia: Recommendations and Potential Impact

L Goldman, J M Teich, K M Kuntz, 1997, Annals of Internal Medicine.

Cost Effectiveness of Age-Specific Screening Intervals for People With Family Histories of Colorectal Cancer.

Elizabeth M. Webber, Marc S. Williams, K. Goddard, 2018, Gastroenterology.

A Systematic Comparison of Microsimulation Models of Colorectal Cancer

Iris Lansdorp-Vogelaar, Marjolein van Ballegooijen, Amy B. Knudsen, 2011, Medical decision making : an international journal of the Society for Medical Decision Making.

Informing Medication Discontinuation Decisions among Older Adults with Relapsing-Onset Multiple Sclerosis

A. Carpenter, K. Kuntz, J. Petkau, 2020, Drugs & Aging.

Optimal management strategy for use of compression US for deep venous thrombosis in symptomatic patients: a cost-effectiveness analysis.

K. Kuntz, J. Cronan, H. M. Kim, 2000, Academic radiology.

Cost-Effectiveness of Allopurinol and Febuxostat for the Management of Gout

Hyon K. Choi, K. Kuntz, L. Pizzi, 2014, Annals of Internal Medicine.

Should postmenopausal women with rheumatoid arthritis who are starting corticosteroid treatment be screened for osteoporosis? A cost-effectiveness analysis.

K. Kuntz, D. Solomon, 2000, Arthritis and rheumatism.

Efficacy, Safety, and Tolerability of Armodafinil Therapy for Hypersomnia Associated with Dementia with Lewy Bodies: A Pilot Study

B. Boeve, W. Kremers, K. Kuntz, 2017, Dementia and Geriatric Cognitive Disorders.

Effects of Categorizing Continuous Variables in Decision-Analytic Models

M. Weinstein, K. Kuntz, T. Bentley, 2009, Medical decision making : an international journal of the Society for Medical Decision Making.

Cost-effectiveness of omalizumab in adults with severe asthma: results from the Asthma Policy Model.

K. Kuntz, A. Fuhlbrigge, A. Wu, 2007, The Journal of allergy and clinical immunology.

Detection of preclinical Parkinson disease in at-risk family members with use of [123I]beta-CIT and SPECT: an exploratory study.

D. Schaid, D. Maraganore, S. McDonnell, 1999, Mayo Clinic proceedings.

Modeling human papillomavirus and cervical cancer in the United States for analyses of screening and vaccination

Jeremy D Goldhaber-Fiebert, Karen M Kuntz, Natasha K Stout, 2007, Population health metrics.

Linear Regression Metamodeling as a Tool to Summarize and Present Simulation Model Results

Hawre Jalal, François Sainfort, Karen M Kuntz, 2013, Medical decision making : an international journal of the Society for Medical Decision Making.

Adding decision models to systematic reviews: informing a framework for deciding when and how to do so.

R. Kane, K. Kuntz, S. Kulasingam, 2013, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Cost-Savings to Medicare From Pre-Medicare Colorectal Cancer Screening

A. Zauber, K. Kuntz, M. van Ballegooijen, 2015, Medical care.

Effects of cognition, function, and behavioral and psychological symptoms on out-of-pocket medical and nursing home expenditures and time spent caregiving for persons with dementia

R. Kane, K. Kuntz, B. Dowd, 2017, Alzheimer's & Dementia.

Carotid endarterectomy in asymptomatic patients--is contrast angiography necessary? A morbidity analysis.

K. Kuntz, K. Kent, A. Whittemore, 1995, Journal of vascular surgery.

Risk Factors Associated With Cognitive, Functional, and Behavioral Trajectories of Newly Diagnosed Dementia Patients

R. Kane, K. Kuntz, B. Dowd, 2017, The journals of gerontology. Series A, Biological sciences and medical sciences.

The length of the hospital stay after myocardial infarction.

E. Antman, K. Kuntz, 2000, The New England journal of medicine.

Validation of Models Used to Inform Colorectal Cancer Screening Guidelines

Tracey L Marsh, Karen M Kuntz, Ann G Zauber, 2016, Medical decision making : an international journal of the Society for Medical Decision Making.

Colorectal Cancer Screening in Young Adults

A. Zauber, C. Rutter, K. Kuntz, 2021, Annals of Internal Medicine.

Decision and Simulation Modeling Alongside Systematic Reviews

R. Kane, K. Kuntz, S. Kulasingam, 2013 .

Cost-effectiveness of second-generation antipsychotics for the treatment of schizophrenia.

K. Kuntz, T. Park, 2014, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Projecting the clinical benefits of adjuvant radiotherapy versus observation and selective salvage radiotherapy after radical prostatectomy: a decision analysis

T. Wilt, K. Kuntz, S. Elliott, 2011, Prostate Cancer and Prostatic Diseases.

Sensitivity of immunochemical faecal occult blood testing for detecting left- vs right-sided colorectal neoplasia

Amy B. Knudsen, H. Brenner, K. Kuntz, 2011, British Journal of Cancer.

A. Carpenter, K. Kuntz, N. Shippee, 2019, Multiple sclerosis.

Safety, Tolerability, and Efficacy of Armodafinil Therapy for Hypersomnia Associated with Dementia with Lewy Bodies (P04.192)

B. Boeve, K. Kuntz, L. Allen, 2012 .

Force of infection of Helicobacter pylori in Mexico: evidence from a national survey using a hierarchical Bayesian model

K. Kuntz, J. Parsonnet, E. Enns, 2018, Epidemiology and Infection.

Clarifying Differences in Natural History between Models of Screening

Carolyn M. Rutter, James E. Savarino, Karen M. Kuntz, 2011, Medical decision making : an international journal of the Society for Medical Decision Making.

The Impact of a Partially Effective HIV Vaccine on a Population of Intravenous Drug Users in Bangkok, Thailand: A Dynamic Model

Karen M. Kuntz, K. Kuntz, Elizabeth Bogard, 2002, Journal of acquired immune deficiency syndromes.

Personalizing age of cancer screening cessation based on comorbid conditions: model estimates of harms and benefits.

Ruth Etzioni, Iris Lansdorp-Vogelaar, Marjolein van Ballegooijen, 2014, Annals of internal medicine.

Papillary Thyroid Cancer: A Classic Example

K. Kuntz, Kathryn M. Kuntz, Diane J. Youngs, 2005 .

Opportunities for Personalizing Colorectal Cancer Care: An Analysis of SEER-Medicare Data

K. Kuntz, J. Farley, P. Jacobson, 2022, The Pharmacogenomics Journal.

Optimizing endocrine therapy in postmenopausal women with early stage breast cancer: A decision analysis for biological subsets of tumors

E. Winer, K. Kuntz, H. Burstein, 2005 .

Reflecting Uncertainty in Cost-Effectiveness Analysis

M. Sculpher, K. Kuntz, D. Meltzer, 2016 .

Comparative responsiveness of generic versus disease-specific and weighted versus unweighted health status measures in carpal tunnel syndrome.

R. Keller, J. Katz, K. Kuntz, 1998, Medical care.

Variability of Preoperative Breast MRI Utilization among Older Women with Newly Diagnosed Early‐stage Breast Cancer

D. Jacobs, K. Kuntz, R. Kane, 2013, The breast journal.

Cost-Effectiveness of Ivacaftor Therapy for Treatment of Cystic Fibrosis Patients With the G551D Gating Mutation.

K. Kuntz, R. Chapman, K. Wherry, 2020, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

The effectiveness and value of novel treatments for cystic fibrosis.

D. Rind, K. Kuntz, J. Tice, 2021, Journal of managed care & specialty pharmacy.

Effects of Cognition, Function, and Behavioral and Psychological Symptoms on Medicare Expenditures and Health Care Utilization for Persons With Dementia

R. Kane, K. Kuntz, B. Dowd, 2017, The journals of gerontology. Series A, Biological sciences and medical sciences.

Association between preference-based health-related quality of life and asthma severity.

K. Blumenschein, M. Moy, K. Kuntz, 2004, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

Development of new non‐invasive tests for colorectal cancer screening: The relevance of information on adenoma detection

K. Kuntz, I. Lansdorp-Vogelaar, A. Knudsen, 2015, International journal of cancer.

Cost-effectiveness of screening for colorectal cancer in the general population.

Graham A. Colditz, Karen M. Kuntz, Charles S. Fuchs, 2000, JAMA.

Hormone testing in women with adult-onset amenorrhea.

R. Barbieri, K. Kuntz, M. Laufer, 1995, Gynecologic and obstetric investigation.

Cost-effectiveness of cervical cancer screening with human papillomavirus DNA testing and HPV-16,18 vaccination.

J. Salomon, K. Kuntz, N. Stout, 2008, Journal of the National Cancer Institute.

The association of preoperative breast magnetic resonance imaging and multiple breast surgeries among older women with early stage breast cancer

D. Jacobs, R. Kane, K. Kuntz, 2013, Breast Cancer Research and Treatment.

Cost-Effectiveness of Diagnostic Strategies for Patients with Chest Pain

K. Kuntz, P. Douglas, K. Fleischmann, 1999, Annals of Internal Medicine.

Risk of Initiating Antiarrhythmic Drug Therapy for Atrial Fibrillation in Patients Admitted to a University Hospital

E. Antman, W. Maisel, K. Kuntz, 1997, Annals of Internal Medicine.

Cost-effectiveness of lay responder defibrillation for out-of-hospital cardiac arrest.

M. Weisfeldt, K. Kuntz, G. Nichol, 2009, Annals of emergency medicine.

Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses: Second Panel on Cost-Effectiveness in Health and Medicine.

T. Trikalinos, M. Sculpher, D. Feeny, 2016, JAMA.

Cost-effectiveness of cervical cancer screening with human papillomavirus DNA testing and HPV-16,18 vaccination.

J. Salomon, K. Kuntz, N. Stout, 2008, Journal of the National Cancer Institute.

Erratum: Cost-effectiveness of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor therapy in older patients with myocardial infarction (Annals of Internal Medicine (2000) 132 (780-787))

J. Avorn, K. Kuntz, G. Jacobson, 2002 .

Estimation of Benefits, Burden, and Harms of Colorectal Cancer Screening Strategies: Modeling Study for the US Preventive Services Task Force.

Amy B. Knudsen, A. Zauber, C. Rutter, 2016, JAMA.

Development of new non‐invasive tests for colorectal cancer screening: The relevance of information on adenoma detection

Amy B. Knudsen, K. Kuntz, I. Lansdorp-Vogelaar, 2015, International journal of cancer.

Modeling for health care and other policy decisions: uses, roles, and validity.

F Reed Johnson, M. Weinstein, F. Johnson, 2002, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.